These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 25781025)

  • 1. A randomised controlled trial of intravenous zoledronic acid in malignant pleural disease: a proof of principle pilot study.
    Clive AO; Hooper CE; Edey AJ; Morley AJ; Zahan-Evans N; Hall D; Lyburn I; White P; Braybrooke JP; Sequeiros I; Lyen SM; Milton T; Kahan BC; Maskell NA
    PLoS One; 2015; 10(3):e0118569. PubMed ID: 25781025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zoledronic acid reduces knee pain and bone marrow lesions over 1 year: a randomised controlled trial.
    Laslett LL; Doré DA; Quinn SJ; Boon P; Ryan E; Winzenberg TM; Jones G
    Ann Rheum Dis; 2012 Aug; 71(8):1322-8. PubMed ID: 22355040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zoledronic acid is effective against experimental malignant pleural effusion.
    Stathopoulos GT; Moschos C; Loutrari H; Kollintza A; Psallidas I; Karabela S; Magkouta S; Zhou Z; Papiris SA; Roussos C; Kalomenidis I
    Am J Respir Crit Care Med; 2008 Jul; 178(1):50-9. PubMed ID: 18388351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of zoledronic acid for chronic low back pain associated with Modic changes in magnetic resonance imaging.
    Koivisto K; Kyllönen E; Haapea M; Niinimäki J; Sundqvist K; Pehkonen T; Seitsalo S; Tervonen O; Karppinen J
    BMC Musculoskelet Disord; 2014 Mar; 15():64. PubMed ID: 24588905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of zoledronic acid on type and volume of Modic changes among patients with low back pain.
    Koivisto K; Järvinen J; Karppinen J; Haapea M; Paananen M; Kyllönen E; Tervonen O; Niinimäki J
    BMC Musculoskelet Disord; 2017 Jun; 18(1):274. PubMed ID: 28645291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis.
    Ball S; Vickery J; Hobart J; Wright D; Green C; Shearer J; Nunn A; Cano MG; MacManus D; Miller D; Mallik S; Zajicek J
    Health Technol Assess; 2015 Feb; 19(12):vii-viii, xxv-xxxi, 1-187. PubMed ID: 25676540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zoledronic acid significantly improves pain scores and quality of life in breast cancer patients with bone metastases: a randomised, crossover study of community vs hospital bisphosphonate administration.
    Wardley A; Davidson N; Barrett-Lee P; Hong A; Mansi J; Dodwell D; Murphy R; Mason T; Cameron D
    Br J Cancer; 2005 May; 92(10):1869-76. PubMed ID: 15870721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial.
    Coleman R; Cameron D; Dodwell D; Bell R; Wilson C; Rathbone E; Keane M; Gil M; Burkinshaw R; Grieve R; Barrett-Lee P; Ritchie D; Liversedge V; Hinsley S; Marshall H;
    Lancet Oncol; 2014 Aug; 15(9):997-1006. PubMed ID: 25035292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single infusion of zoledronic acid produces sustained remissions in Paget disease: data to 6.5 years.
    Reid IR; Lyles K; Su G; Brown JP; Walsh JP; del Pino-Montes J; Miller PD; Fraser WD; Cafoncelli S; Bucci-Rechtweg C; Hosking DJ
    J Bone Miner Res; 2011 Sep; 26(9):2261-70. PubMed ID: 21638319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life in men with locally advanced prostate cancer treated with leuprorelin and radiotherapy with or without zoledronic acid (TROG 03.04 RADAR): secondary endpoints from a randomised phase 3 factorial trial.
    Denham JW; Wilcox C; Joseph D; Spry NA; Lamb DS; Tai KH; Matthews J; Atkinson C; Turner S; Christie D; Gogna NK; Kenny L; Duchesne G; Delahunt B; McElduff P
    Lancet Oncol; 2012 Dec; 13(12):1260-70. PubMed ID: 23151431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Outcomes and Survival Following Treatment of Metastatic Castrate-Refractory Prostate Cancer With Docetaxel Alone or With Strontium-89, Zoledronic Acid, or Both: The TRAPEZE Randomized Clinical Trial.
    James ND; Pirrie SJ; Pope AM; Barton D; Andronis L; Goranitis I; Collins S; Daunton A; McLaren D; O'Sullivan J; Parker C; Porfiri E; Staffurth J; Stanley A; Wylie J; Beesley S; Birtle A; Brown J; Chakraborti P; Hussain S; Russell M; Billingham LJ
    JAMA Oncol; 2016 Apr; 2(4):493-9. PubMed ID: 26794729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of pain in elderly patients receiving infusion of zoledronic acid for bone metastasis: a single-institution report.
    Addeo R; Nocera V; Faiola V; Vincenzi B; Ferraro G; Montella L; Guarrasi R; Rossi E; Cennamo G; Tonini G; Capasso E; Santini D; Caraglia M; Del Prete S
    Support Care Cancer; 2008 Feb; 16(2):209-14. PubMed ID: 17701225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease.
    Reid IR; Miller P; Lyles K; Fraser W; Brown JP; Saidi Y; Mesenbrink P; Su G; Pak J; Zelenakas K; Luchi M; Richardson P; Hosking D
    N Engl J Med; 2005 Sep; 353(9):898-908. PubMed ID: 16135834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous vertebroplasty combined with zoledronic acid for the treatment of painful osteolytic spinal metastases in patients with breast cancer.
    Zhang J; Wang Y; Han K; Tang L; Hu H; Wu C; Shen Z; Sun Y; Yao Y
    J Vasc Interv Radiol; 2013 Dec; 24(12):1861-7. PubMed ID: 24144536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of combined androgen blockade with zoledronic acid treatment in prostate cancer with bone metastasis: the ZABTON-PC (zoledronic acid/androgen blockade trial on prostate cancer) study.
    Ueno S; Mizokami A; Fukagai T; Fujimoto N; Oh-Oka H; Kondo Y; Arai G; Ide H; Horie S; Ueki O; Kawaguchi K; Shimamura M; Orito M; Ishida T; Ikeda D; Namiki M
    Anticancer Res; 2013 Sep; 33(9):3837-44. PubMed ID: 24023317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, phase III, double-blind, placebo-controlled trial of intrapleural instillation of methylprednisolone acetate in the management of malignant pleural effusion.
    North SA; Au HJ; Halls SB; Tkachuk L; Mackey JR
    Chest; 2003 Mar; 123(3):822-7. PubMed ID: 12628884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous or nebulised magnesium sulphate versus standard therapy for severe acute asthma (3Mg trial): a double-blind, randomised controlled trial.
    Goodacre S; Cohen J; Bradburn M; Gray A; Benger J; Coats T;
    Lancet Respir Med; 2013 Jun; 1(4):293-300. PubMed ID: 24429154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of single-dose zoledronic acid for osteoporosis in frail elderly women: a randomized clinical trial.
    Greenspan SL; Perera S; Ferchak MA; Nace DA; Resnick NM
    JAMA Intern Med; 2015 Jun; 175(6):913-21. PubMed ID: 25867538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous zoledronic acid in postmenopausal women with low bone mineral density.
    Reid IR; Brown JP; Burckhardt P; Horowitz Z; Richardson P; Trechsel U; Widmer A; Devogelaer JP; Kaufman JM; Jaeger P; Body JJ; Brandi ML; Broell J; Di Micco R; Genazzani AR; Felsenberg D; Happ J; Hooper MJ; Ittner J; Leb G; Mallmin H; Murray T; Ortolani S; Rubinacci A; Saaf M; Samsioe G; Verbruggen L; Meunier PJ
    N Engl J Med; 2002 Feb; 346(9):653-61. PubMed ID: 11870242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermittent zoledronic Acid prevents bone loss in adults after allogeneic hematopoietic cell transplantation.
    Hari P; DeFor TE; Vesole DH; Bredeson CN; Burns LJ
    Biol Blood Marrow Transplant; 2013 Sep; 19(9):1361-7. PubMed ID: 23806773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.